Your browser doesn't support javascript.
loading
Modulation of glycolysis and lipogenesis by novel PI3K selective molecule represses tumor angiogenesis and decreases colorectal cancer growth.
Hussain, Aashiq; Qazi, Asif Khurshid; Mupparapu, Nagaraju; Guru, Santosh Kumar; Kumar, Ashok; Sharma, Parduman Raj; Singh, Shashank Kumar; Singh, Paramjit; Dar, Mohd Jamal; Bharate, Sandip B; Zargar, Mohmmad Afzal; Ahmed, Qazi Naveed; Bhushan, Shashi; Vishwakarma, Ram A; Hamid, Abid.
Afiliação
  • Hussain A; Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India.
  • Qazi AK; Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India.
  • Mupparapu N; Medicinal Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India.
  • Guru SK; Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India.
  • Kumar A; Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India.
  • Sharma PR; Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India.
  • Singh SK; Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India.
  • Singh P; Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India.
  • Dar MJ; Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India.
  • Bharate SB; Medicinal Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India.
  • Zargar MA; Department of Biochemistry, University of Kashmir, Srinagar, 190006, India.
  • Ahmed QN; Medicinal Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India.
  • Bhushan S; Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India.
  • Vishwakarma RA; Medicinal Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India.
  • Hamid A; Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India. Electronic address: ahdar@iiim.ac.in.
Cancer Lett ; 374(2): 250-60, 2016 May 01.
Article em En | MEDLINE | ID: mdl-26921131
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Inibidores de Proteínas Quinases / Quinazolinonas / Inibidores de Fosfoinositídeo-3 Quinase / Naftalenos Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Inibidores de Proteínas Quinases / Quinazolinonas / Inibidores de Fosfoinositídeo-3 Quinase / Naftalenos Idioma: En Ano de publicação: 2016 Tipo de documento: Article